Skip to content

TDACW

Translational Development Acquisition Corp.

NASDAQ · Financial Services · Financial - Conglomerates · US

$1.25
+9.65%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue—————
Gross Profit(23.2K)————
Operating Expenses
R&D Expense—————
SG&A Expense1.3M944.5K196.4K485.6K70.7K
General & Admin Expense1.3M944.5K196.4K485.6K70.7K
Selling & Marketing Expense—————
Other Expenses—————
Total Operating Expenses1.3M944.5K196.4K485.6K70.7K
Cost and Expenses1.3M944.5K196.4K485.6K70.7K
Operating Income (EBIT)(1.3M)(944.5K)(196.4K)(485.6K)(70.7K)
Non-Operating
Interest Income1.9M————
Interest Expense(7.7K)————
Net Interest Income3.5M————
Other Non-Op Income/Expense6.9M7.3M125.3K——
Non-Operating Income (excl Interest)—————
EBT (Pre-Tax Income)5.5M6.4M(71.0K)(485.6K)(70.7K)
Income Tax Expense—————
Bottom Line
Net Income5.5M6.4M(71.0K)(485.6K)(70.7K)
Earnings from Cont. Ops5.5M6.4M(71.0K)(485.6K)(70.7K)
Earnings from Discont. Ops—————
Bottom Line Net Income5.5M6.4M(71.0K)(485.6K)(70.7K)
Per Share
Basic EPS$0.26$0.37($0.02)($0.03)($0.02)
Diluted EPS$0.26$0.37($0.02)($0.03)($0.02)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding16.9M17.3M4.4M19.1M4.0M
Diluted Shares Outstanding16.9M17.3M4.4M19.1M4.0M
Profitability Metrics
EBITDA(1.3M)(944.5K)(196.4K)(485.6K)—
D&A————70.7K
EBIT(1.3M)(944.5K)(196.4K)(485.6K)(70.7K)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026